Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients
Clinical trial NCT06051565 · COMPLETED
Trial details
- NCT number
- NCT06051565
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-06
- Primary completion
- 2022-06-13
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.